83575-39-7 Usage
Uses
Used in Pharmaceutical Industry:
(S)-2-amino-5-[(aminocarbonyl)amino]-N-(4-nitrophenyl)valeramide monohydrobromide is used as a potential pharmaceutical compound for its unique structural properties that may offer novel therapeutic avenues. (S)-2-amino-5-[(aminocarbonyl)amino]-N-(4-nitrophenyl)valeramide monohydrobromide's specific application within the pharmaceutical industry will depend on the outcomes of ongoing research and development.
Used in Biochemical Research:
In the field of biochemical research, (S)-2-amino-5-[(aminocarbonyl)amino]-N-(4-nitrophenyl)valeramide monohydrobromide serves as a subject of study to explore its interactions with biological systems. Its structural features may provide insights into new mechanisms of action or reveal potential targets for drug design.
Check Digit Verification of cas no
The CAS Registry Mumber 83575-39-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,5,7 and 5 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 83575-39:
(7*8)+(6*3)+(5*5)+(4*7)+(3*5)+(2*3)+(1*9)=157
157 % 10 = 7
So 83575-39-7 is a valid CAS Registry Number.
InChI:InChI=1/C12H17N5O4.BrH/c13-10(2-1-7-15-12(14)19)11(18)16-8-3-5-9(6-4-8)17(20)21;/h3-6,10H,1-2,7,13H2,(H,16,18)(H3,14,15,19);1H
83575-39-7Relevant academic research and scientific papers
PREPARATION AND PROPERTIES OF SOME CITRULLINE p-NITROANILIDE DERIVARIVES FOR POSSIBLE USE AS PROTEASE SUBSTRATES
Gray, C. J.,Boukouvalas, J.,Barker, S. A.
, p. 1465 - 1470 (2007/10/02)
A number of citrulline p-nitroanilides have been synthesised as potential substrates for proteolytic enzymes.Nα-Benzyloxycarbonyl-L-citrulline p-nitroanilide, a key starting material, was prepared by the phosphoazo method.During this reaction, depending on the conditions, lactam formation and decarbamoylation took place.It is probable that decarbamoylation took place subsequent to the lactamisation step.The derivatives prepared included some protected tripeptide nitroanilides, benzyloxycarbonylglycyl-L-prolyl-L-citrulline p-nitroanilide, benzyloxycarbonyl-D-phenylalanyl-L-prolyl-L-citrulline p- nitroanilide, benzyloxycarbonylglycyl-L-phenylalanyl-L-citrulline p-nitroanilide, methyloxycarbonylglycyl-L-phenylalanyl-L-citrulline p-nitroanilide and a protected tetrapeptide, benzyloxycarbonylglycyl glycyl-L-phenylalanyl-L-citrulline p-nitroanilide.Preliminary results have indicated that citrulline p-nitroanilides are far more susceptible to hydrolysis by plant thiol enzymes such as papain, ficin and bromelain than by mammalian proteases.
